SELLAS Life Sciences Group Inc (SLS)
1.51
+0.10
(+7.09%)
USD |
NASDAQ |
Apr 18, 16:00
1.53
+0.02
(+1.32%)
After-Hours: 20:00
SELLAS Life Sciences Group Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.0041 |
| June 30, 2018 | -3.133 |
| March 31, 2018 | -7.341 |
| December 31, 2017 | 5.308 |
| Date | Value |
|---|---|
| September 30, 2017 | 0.8315 |
| June 30, 2017 | 0.681 |
| March 31, 2017 | 0.4632 |
| December 31, 2016 | -1.474 |
| September 30, 2016 | 0.9913 |
| June 30, 2016 | 1.140 |
| March 31, 2016 | 0.3013 |
| December 31, 2015 | 0.3507 |
| September 30, 2015 | 0.1756 |
| June 30, 2015 | 0.1342 |
| March 31, 2015 | 0.1274 |
| December 31, 2014 | 0.2267 |
| September 30, 2014 | 0.3001 |
| June 30, 2014 | 0.356 |
| March 31, 2014 | 0.2147 |
| December 31, 2013 | 1.681 |
| September 30, 2013 | 0.283 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2019
--
Maximum
Jun 2019
--
Average
--
Median
Jun 2019
Debt to Equity Ratio Benchmarks
| Geron Corp | 0.3305 |
| Immuneering Corp | -- |
| Protagonist Therapeutics Inc | 0.00 |
| Akebia Therapeutics Inc | -1.134 |
| Moderna Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 6.219M |
| Total Liabilities (Quarterly) | 14.20M |
| Shareholders Equity (Quarterly) | -7.976M |